FDA Tightens Rules for Using Mesh Implants in Prolapse Repair

Share this content:
FDA Tightens Rules for Using Mesh Implants in Prolapse Repair
FDA Tightens Rules for Using Mesh Implants in Prolapse Repair

TUESDAY, Jan. 5, 2016 (HealthDay News) -- The U.S. Food and Drug Administration has strengthened rules regarding the use of vaginal mesh implants to treat pelvic organ prolapse in women, according to a news release issued by the agency.

The devices were reclassified on Monday from a "moderate" to "high" risk category. Manufacturers must now submit pre-market approval applications to the FDA to help the agency better assess the implants' safety and effectiveness.

"These stronger clinical requirements will help to address the significant risks associated with surgical mesh for repair of pelvic organ prolapse," William Maisel, M.D., M.P.H., deputy director of science and chief scientist at the FDA's Center for Devices and Radiological Health, said in the news release. "We intend to continue monitoring how women with this device are faring months and years after surgery through continued post-market surveillance measures."

The updated requirements apply to transvaginal placement of the mesh implants to treat pelvic organ prolapse. The new rules do not apply to other uses of surgical mesh. Makers of transvaginal mesh implants already on the market now have 30 months to submit pre-market approval applications, while makers of new devices must submit an application before their devices can be approved for sale in the United States, the FDA said.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »